Mersana Therapeutics, Inc.

MRSN · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$107,750$174,561$128,885$177,947
Short-Term Investments$26,870$34,523$151,827$0
Receivables$0$0$30,000$0
Inventory$0$0$0$0
Other Curr. Assets$2,284$4,973$8,507$10,951
Total Curr. Assets$136,904$214,057$319,219$188,898
Property Plant & Equip (Net)$6,781$11,525$14,460$14,857
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$478
Tax Assets$0$0$0$0
Other NC Assets$978$478$661$1,878
Total NC Assets$7,759$12,003$15,121$17,213
Other Assets$0$0$0$0
Total Assets$144,663$226,060$334,340$206,111
Liabilities
Payables$4,330$7,319$13,951$12,321
Short-Term Debt$16,356$5,479$2,798$2,303
Tax Payable$0$0$0$0
Deferred Revenue$22,168$28,147$30,610$3,944
Other Curr. Liab.$19,604$22,692$44,174$28,955
Total Curr. Liab.$62,458$63,637$91,533$47,523
LT Debt$12,242$28,351$33,504$35,873
Deferred Rev, NC$79,464$97,167$117,043$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$8$1$203$974
Total NC Liab.$91,714$125,519$150,750$36,847
Other Liabilities$0$0$0$0
Cap. Leases$5,148$8,599$11,373$13,550
Total Liabilities$154,172$189,156$242,283$84,370
Equity
Pref Stock$0$0$0$0
Common Stock$12$12$11$7
Retained Earnings-$895,553-$826,361-$654,691-$450,479
AOCI$10$11-$152$0
Other Equity$886,022$863,242$746,889$572,213
Total Equity-$9,509$36,904$92,057$121,741
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$144,663$226,060$334,340$206,111
Net Debt-$79,152-$140,731-$92,583-$139,771